Literature DB >> 24079399

Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011.

Z Memish1, R Al Hakeem, O Al Neel, K Danis, A Jasir, D Eibach.   

Abstract

Saudi Arabia (SA) experienced two large invasive meningococcal disease (IMD) outbreaks during the 2000 and 2001 Hajj pilgrimages. In 2002, polysaccharide quadrivalent ACWY vaccines became mandatory for Mecca and Medina pilgrims/residents older than two years. This study aimed to analyse IMD surveillance data among citizens, residents and pilgrims in SA from 1995 to 2011, focusing on changes before and after the new vaccination policy. For all laboratory-confirmed IMD cases in the national surveillance database from 1995 to 2011, serogroup and age were retrieved. The cases' seasonal distribution as well as the case fatality ratios (CFR) were obtained. For Saudi citizens/residents and Hajj pilgrims, annual rates were calculated using mid-year population estimates. The Student's t-test was used to compare means between the pre-epidemic (1995-1999) and post-epidemic (2002-2011) periods, excluding outbreak years. From 1995 to 2011, laboratories notified 1,103 cases. Between the pre- and post-epidemic periods, mean annual IMD rates decreased from 0.20 (standard deviation (SD): 0.1) to 0.06 cases/100,000 (SD: 0.06; p=0.02), mean numbers of Hajj-related cases from 13 (SD: 9.3) to 2 cases/year (SD: 2.3; p=0.02) and the mean age from 31 (SD: 1.3) to 18 years (SD: 1.4; p<0.01). The CFR in Saudi citizens (10.4) was lower than among foreign pilgrims (28.9) and decreased from 19.3% (SD: 1.8) in the pre-epidemic to 11.4% (SD: 7.0; p=0.04) in the post-epidemic phase. The decrease of annual IMD rates, CFR and Hajj-related cases between the pre- and post- vaccine era suggests a possible positive effect of the mandatory ACWY vaccination for pilgrims/residents in Mecca and Medina. Regular surveillance with an annual data analysis is necessary to monitor trends and circulating serotypes and to implement appropriate public health measures to avoid new IMD epidemics during upcoming Hajj seasons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24079399     DOI: 10.2807/1560-7917.es2013.18.37.20581

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  14 in total

1.  Meningococcal carriage among Hajj pilgrims, risk factors for carriage and records of vaccination: a study of pilgrims to Mecca.

Authors:  Abrar Alasmari; Joanna Houghton; Brian Greenwood; David Heymann; Phil Edwards; Heidi Larson; Abdullah Assiri; Fathia Ben-Rached; Arnab Pain; Ron Behrens; Amaya Bustinduy
Journal:  Trop Med Int Health       Date:  2021-01-31       Impact factor: 2.622

2.  Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial.

Authors:  Charissa Fay Corazon Borja-Tabora; Cecilia Montalban; Ziad A Memish; Dominique Boutriau; Devayani Kolhe; Jacqueline M Miller; Marie Van der Wielen
Journal:  BMC Infect Dis       Date:  2015-10-06       Impact factor: 3.090

Review 3.  Vaccination in Hajj: An Overview of the Recent Findings.

Authors:  Seyed Mansour Razavi; Mina Saeednejad; Payman Salamati
Journal:  Int J Prev Med       Date:  2016-12-15

4.  Surveillance of Australian Hajj pilgrims for carriage of potentially pathogenic bacteria: Data from two pilot studies.

Authors:  Mohammad Irfan Azeem; Mohamed Tashani; Al-Mamoon Badahdah; Leon Heron; Kristen Pedersen; Neisha Jeoffreys; Jen Kok; Elizabeth Haworth; Dominic E Dwyer; Grant Hill-Cawthorne; Harunor Rashid; Robert Booy
Journal:  World J Clin Cases       Date:  2017-03-16       Impact factor: 1.337

Review 5.  Hajj: infectious disease surveillance and control.

Authors:  Ziad A Memish; Alimuddin Zumla; Rafat F Alhakeem; Abdullah Assiri; Abdulhafeez Turkestani; Khalid D Al Harby; Mohamed Alyemni; Khalid Dhafar; Philippe Gautret; Maurizio Barbeschi; Brian McCloskey; David Heymann; Abdullah A Al Rabeeah; Jaffar A Al-Tawfiq
Journal:  Lancet       Date:  2014-05-20       Impact factor: 79.321

Review 6.  Expected immunizations and health protection for Hajj and Umrah 2018 -An overview.

Authors:  Jaffar A Al-Tawfiq; Philippe Gautret; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2017-10-14       Impact factor: 6.211

Review 7.  Incidence and Prevention of Invasive Meningococcal Disease in Global Mass Gathering Events.

Authors:  Abdul Razak Muttalif; Jessica V Presa; Hammam Haridy; Amgad Gamil; Lidia C Serra; Alejandro Cané
Journal:  Infect Dis Ther       Date:  2019-08-30

8.  Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers.

Authors:  Al-Mamoon Badahdah; Fatimah Alghabban; Wajd Falemban; Abdullah Albishri; Gouri Rani Banik; Tariq Alhawassi; Hatem Abuelizz; Marwan A Bakarman; Ameneh Khatami; Robert Booy; Harunor Rashid
Journal:  Trop Med Infect Dis       Date:  2019-10-15

9.  Statement on Meningococcal Disease and the International Traveller.

Authors:  A McCarthy
Journal:  Can Commun Dis Rep       Date:  2015-05-07

Review 10.  Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries.

Authors:  Molly Sauer; Prarthana Vasudevan; Ankita Meghani; Karuna Luthra; Cristina Garcia; Maria Deloria Knoll; Lois Privor-Dumm
Journal:  Vaccine       Date:  2021-02-19       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.